Related Experiment Video
Updated: Sep 3, 2025

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
Published on: July 18, 2012
Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against Candida albicans
Majid Rasool Kamli1,2, Elham A Alzahrani3, Soha M Albukhari3
1Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.
Abstract:
The increasing frequency of antifungal drug resistance among pathogenic yeast "Candida" has posed an immense global threat to the public healthcare sector. The most notable species of Candida causing most fungal infections is Candida albicans. Furthermore, recent research has revealed that transition and noble metal combinations can have synergistic antimicrobial effects. Therefore, a one-pot seedless biogenic synthesis of Ag-Ni bimetallic nanoparticles (Ag-Ni NPs) using Salvia officinalis aqueous leaf extract is described. Various techniques, such as UV-vis, FTIR, XRD, SEM, EDX, and TGA, were used to validate the production of Ag-Ni NPs. The antifungal susceptibility of Ag-Ni NPs alone and in combination with fluconazole (FLZ) was tested against FLZ-resistant C. albicans isolate. Furthermore, the impacts of these NPs on membrane integrity, drug efflux pumps, and biofilms formation were evaluated. The MIC (1.56 μg/mL) and MFC (3.12 μg/mL) results indicated potent antifungal activity of Ag-Ni NPs against FLZ-resistant C. albicans. Upon combination, synergistic interaction was observed between Ag-Ni NPs and FLZ against C. albicans 5112 with a fractional inhibitory concentration index (FICI) value of 0.31. In-depth studies revealed that Ag-Ni NPs at higher concentrations (3.12 μg/mL) have anti-biofilm properties and disrupt membrane integrity, as demonstrated by scanning electron microscopy results. In comparison, morphological transition was halted at lower concentrations (0.78 μg/mL). From the results of efflux pump assay using rhodamine 6G (R6G), it was evident that Ag-Ni NPs blocks the efflux pumps in the FLZ-resistant C. albicans 5112. Targeting biofilms and efflux pumps using novel drugs will be an alternate approach for combatting the threat of multi-drug resistant (MDR) stains of C. albicans. Therefore, this study supports the usage of Ag-Ni NPs to avert infections caused by drug resistant strains of C. albicans.
Insights
Silver-nickel nanoparticles (Ag-Ni NPs) show potent antifungal activity against drug-resistant Candida albicans. These nanoparticles synergize with fluconazole, disrupt biofilms, and block efflux pumps, offering a novel approach to combatting resistant fungal infections.
Area of Science:
- Nanotechnology
- Mycology
- Biochemistry
Background:
- Antifungal drug resistance in Candida species, particularly Candida albicans, presents a significant global health challenge.
- Combinations of transition and noble metals have demonstrated synergistic antimicrobial effects.
- Salvia officinalis leaf extract can be utilized for biogenic synthesis of metal nanoparticles.
Purpose of the Study:
- To synthesize silver-nickel bimetallic nanoparticles (Ag-Ni NPs) using Salvia officinalis leaf extract.
- To evaluate the antifungal activity of Ag-Ni NPs, alone and in combination with fluconazole (FLZ), against FLZ-resistant Candida albicans.
- To investigate the impact of Ag-Ni NPs on Candida albicans membrane integrity, efflux pumps, and biofilm formation.
Main Methods:
- One-pot seedless biogenic synthesis of Ag-Ni NPs using Salvia officinalis aqueous leaf extract.
- Characterization of Ag-Ni NPs using UV-vis, FTIR, XRD, SEM, EDX, and TGA.
- Antifungal susceptibility testing (MIC, MFC), synergy testing (FICI), membrane integrity assays, efflux pump assays (rhodamine 6G), and biofilm inhibition assays.
Main Results:
- Ag-Ni NPs exhibited potent antifungal activity against fluconazole-resistant Candida albicans with MIC of 1.56 μg/mL and MFC of 3.12 μg/mL.
- A synergistic interaction was observed between Ag-Ni NPs and fluconazole (FICI = 0.31).
- Ag-Ni NPs disrupted membrane integrity, inhibited biofilm formation at higher concentrations, halted morphological transition at lower concentrations, and blocked efflux pumps in resistant strains.
Conclusions:
- Biogenically synthesized Ag-Ni NPs demonstrate significant antifungal efficacy against drug-resistant Candida albicans.
- Ag-Ni NPs show synergistic effects with fluconazole and possess multi-modal mechanisms of action, including biofilm disruption and efflux pump inhibition.
- Ag-Ni NPs represent a promising therapeutic candidate for combating infections caused by multi-drug resistant Candida strains.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antimicrobial Effectiveness

